, Sex (n) Female (45), male (29)

, Simpson grade (n) Grade

, Five-year survival Progression free survival: Grade I: 58%

I. I. Grade, , p.36

, Grade III: 14% Overall survival: Grade I: 97%

I. I. Grade, , p.88

I. Grade, Anaplastic: 18.9% (14/74) Transitional or mixed

, HSP27 SQ score (mean ± SEM, range) Total: 3.7 ± 0.3, range 9, pp.0-9

, Grade I: 3.7± 0.5, range 9, pp.0-9

, Grade II: 3.2± 0.5, range 9, pp.0-9

, Grade III: 5.2± 0.8, range 9, pp.0-9

, HSP27 density (AU; mean ± SEM, range) Total: 158.10 6 ± 2.10 6 , range 715, vol.10, pp.0-715

, Grade I: 104.10 6 ± 15.10 6 , range 31, vol.10, pp.0-313

, Grade II:116.10 6 ± 16.10 6 , range 29, vol.10, pp.0-290

, Grade III: 360.10 6 ± 49.10 6 , range 71, vol.10, pp.0-715

, HSP70 SQ score (AU; mean ± SEM, range) Total: 5.2± 0.3, range 9, pp.0-9

, Grade I: 4.9± 0.5, range 9, pp.0-9

, Grade III: 7.7± 0.6, range 9, pp.0-9

, HSP70 density (AU; mean ± SEM, range) Total: 225.10 6 ± 2,6.10 6 ; range 729, vol.10, pp.0-729

, Grade I: 145.10 6 ± 20.10 6 , range 525.10, vol.6, pp.0-525

, Grade II: 147.10 6 ± 21.10 6 , range 440, vol.10, pp.0-440

, Grade III: 546.10 6 ± 37.10 6 , range 729, vol.10, pp.0-729

, SQ score: semi quantitative score; SEM: standard error of mean; SD: standard deviation; WHO: World Health Organization

K. S. Mäkelä, J. A. Haapasalo, J. M. Ilvesaro, S. Parkkila, T. Paavonen et al.,

, Hsp27 and its expression pattern in diffusely infiltrating astrocytomas, Histol Histopathol, vol.29, issue.9, pp.1161-1169, 2014.

S. K. Calderwood and J. Ong, eat Shock Proteins Promote ancer: t's a Protection Racket, Trends Biochem Sci, vol.41, issue.4, pp.311-334, 2016.

D. , H. O. , O. W. , and W. K. , WHO Classification of Tumours of the Central Nervous System, Classification-Of-Tumours/Who-Classification-Of-Tumours-Of-The-Central-NervousSystem-2016 4. Search of: Recruiting, Active, not recruiting, Completed, Enrolling by invitation, Unknown status Studies | HSP inhibitor-List Results-ClinicalTrials.gov

X. Wang, M. Chen, J. Zhou, and X. Zhang, HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review), Int J Oncol, vol.45, issue.1, pp.18-30, 2014.

J. C. Heinrich, S. Donakonda, V. J. Haupt, P. Lennig, Y. Zhang et al., New HSP27 inhibitors efficiently suppress drug resistance development in cancer cells, Oncotarget, vol.7, issue.42, pp.68156-69, 2016.

O. Sagol, B. Tuna, A. Coker, S. Karademir, F. Obuz et al., Immunohistochemical detection of pS2 protein and heat shock protein-70 in pancreatic adenocarcinomas. Relationship with disease extent and patient survival, Pathol Res Pract, vol.198, issue.2, pp.77-84, 2002.

C. Schäfer, H. Seeliger, D. C. Bader, G. Assmann, D. Buchner et al., Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma, J Cell Mol Med, vol.16, issue.8, pp.1776-91, 2012.

H. Khalid, K. Tsutsumi, H. Yamashita, M. Kishikawa, A. Yasunaga et al., Expression of the small heat shock protein (hsp) 27 in human astrocytomas correlates with histologic grades and tumor growth fractions, Cell Mol Neurobiol, vol.15, issue.2, pp.257-68, 1995.

E. M. Tweedle, I. Khattak, C. W. Ang, T. Nedjadi, R. Jenkins et al., Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer, Gut, vol.59, issue.11, pp.1501-1511, 2010.

C. Giaginis, S. S. Daskalopoulou, S. Vgenopoulou, I. Sfiniadakis, G. Kouraklis et al., Heat Shock Protein-27,-60 and-90 expression in gastric cancer: association with clinicopathological variables and patient survival, BMC Gastroenterol, vol.9, p.14, 2009.

H. Uozaki, T. Ishida, C. Kakiuchi, H. Horiuchi, T. Gotoh et al., Expression of heat shock proteins in osteosarcoma and its relationship to prognosis, Pathol Res Pract, vol.196, issue.10, pp.665-73, 2000.

C. Liu, J. , Y. Ko, B. Wu, Y. Liang et al., 14-3-3? induces heat shock protein 70 expression in hepatocellular carcinoma, BMC Cancer, vol.14, p.425, 2014.

G. H. Kang, B. S. Lee, E. S. Lee, S. H. Kim, H. Y. Lee et al., Prognostic significance of p53, mTOR, c-Met, IGF-1R, and HSP70 overexpression after the resection of hepatocellular carcinoma, Gut Liver, vol.8, issue.1, pp.79-87, 2014.

H. W. Lee, E. H. Lee, S. Kim, M. S. Roh, S. B. Jung et al., Heat shock protein 70 (HSP70) expression is associated with poor prognosis in intestinal type gastric cancer, Virchows Arch Int J Pathol, vol.463, issue.4, pp.489-95, 2013.

B. Farkas, M. Hantschel, M. Magyarlaki, B. Becker, K. Scherer et al., Heat shock protein 70 membrane expression and melanoma-associated marker phenotype in primary and metastatic melanoma, Melanoma Res, vol.13, issue.2, pp.147-52, 2003.

K. Bauer, U. Nitsche, J. Slotta-huspenina, E. Drecoll, C. H. Von-weyhern et al., High HSP27 and HSP70 expression levels are independent adverse prognostic factors in primary resected colon cancer, Cell Oncol Dordr, vol.35, issue.3, pp.197-205, 2012.

G. Gauchotte, C. Vigouroux, F. Rech, S. Battaglia-hsu, M. Soudant et al., Expression of minichromosome maintenance MCM6 protein in meningiomas is strongly correlated with histologic grade and clinical outcome, Am J Surg Pathol, vol.36, issue.2, pp.283-91, 2012.

G. A. Alexiou, A. Karamoutsios, G. Lallas, V. Ragos, A. Goussia et al., Expression of heat shock proteins in brain tumors, Turk Neurosurg, vol.24, issue.5, pp.745-754, 2014.

M. A. Vogelbaum, L. Rogers, C. Linskey, M. A. Mehta, and M. P. , Opportunities for clinical research in meningioma, J Neurooncol, vol.99, issue.3, pp.417-439, 2010.

G. Jego, A. Hazoumé, R. Seigneuric, and C. Garrido, Targeting heat shock proteins in cancer, Cancer Lett, vol.332, issue.2, pp.275-85, 2013.

D. , H. O. , O. W. , and W. K. , WHO Classification of Tumours of the Central Nervous System, 2016.

, Flint-Richter P, Sadetzki S. Genetic predisposition for the development of radiation-associated meningioma: an epidemiological study, Lancet Oncol, vol.8, issue.5, pp.403-413, 2007.

C. Mawrin and A. Perry, Pathological classification and molecular genetics of meningiomas, J Neurooncol, vol.99, issue.3, pp.379-91, 2010.

M. Kalamarides, M. Niwa-kawakita, H. Leblois, V. Abramowski, M. Perricaudet et al., Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse, Genes Dev, vol.16, issue.9, pp.1060-1065, 2002.

, Tumeurs intracrâniennes

F. Labrousse, Meningiomes:histopronostic. AIP bulletin N°54, 2011.

M. J. Riemenschneider, A. Perry, and G. Reifenberger, Histological classification and molecular genetics of meningiomas, Lancet Neurol, vol.5, issue.12, pp.1045-54, 2006.

G. Gauchotte, C. Vigouroux, F. Rech, S. Battaglia-hsu, M. Soudant et al., Expression of minichromosome maintenance MCM6 protein in meningiomas is strongly correlated with histologic grade and clinical outcome, Am J Surg Pathol, vol.36, issue.2, pp.283-91, 2012.

S. Milker-zabel, P. Huber, W. Schlegel, J. Debus, -. Zabel et al., Fractionated stereotactic radiation therapy in the management of primary optic nerve sheath meningiomas, J Neurooncol, vol.94, issue.3, pp.419-443, 2009.

W. P. Mason, F. Gentili, D. R. Macdonald, S. Hariharan, C. R. Cruz et al., Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma, J Neurosurg, vol.97, issue.2, pp.341-347, 2002.

N. W. Uy, S. Y. Woo, B. S. Teh, W. Y. Mai, L. S. Carpenter et al., Intensity-modulated radiation therapy (IMRT) for meningioma, Int J Radiat Oncol Biol Phys, vol.53, issue.5, pp.1265-70, 2002.

J. P. Maire, D. Liguoro, S. Galli, and F. , Gross tumor volume (GTV) and clinical target volume (CTV) in

, Cancer Radiother J Soc Francaise Radiother Oncol, vol.5, issue.5, pp.581-96, 2001.

G. Noël, A. Renard, C. Valéry, K. Mokhtari, and J. J. Mazeron,

, Cancer Radiother J Soc Francaise Radiother Oncol, vol.5, issue.3, pp.217-253, 2001.

B. W. Taylor, R. B. Marcus, W. A. Friedman, W. E. Ballinger, and R. R. Million, The meningioma controversy: postoperative radiation therapy, Int J Radiat Oncol Biol Phys, vol.15, issue.2, pp.299-304, 1988.

N. M. Barbaro, P. H. Gutin, C. B. Wilson, G. E. Sheline, E. B. Boldrey et al., Radiation therapy in the treatment of partially resected meningiomas, Neurosurgery, vol.20, issue.4, pp.525-533, 1987.

A. Mahmood, N. H. Qureshi, and G. M. Malik, Intracranial meningiomas: analysis of recurrence after surgical treatment, Acta Neurochir (Wien), vol.126, issue.2-4, pp.53-61, 1994.

R. Miralbell, R. M. Linggood, S. De-la-monte, K. Convery, J. E. Munzenrider et al., The role of radiotherapy in the treatment of subtotally resected benign meningiomas, J Neurooncol, vol.13, issue.2, pp.157-64, 1992.

C. Boskos, L. Feuvret, G. Noel, J. Habrand, P. Pommier et al., Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma, Int J Radiat Oncol Biol Phys, vol.75, issue.2, pp.399-406, 2009.
DOI : 10.1016/j.ijrobp.2008.10.053

S. Milker-zabel, A. Zabel, D. Schulz-ertner, W. Schlegel, M. Wannenmacher et al., Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors, Int J Radiat Oncol Biol Phys, vol.61, issue.3, pp.809-825, 2005.
DOI : 10.1016/j.ijrobp.2004.07.669

A. A. Khalil, N. F. Kabapy, S. F. Deraz, and C. Smith, Heat shock proteins in oncology: diagnostic biomarkers or therapeutic targets?, Biochim Biophys Acta, vol.1816, issue.2, pp.89-104, 2011.

M. Dobbelstein and U. Moll, Targeting tumour-supportive cellular machineries in anticancer drug development, Nat Rev Drug Discov, vol.13, issue.3, pp.179-96, 2014.
DOI : 10.1038/nrd4201

C. Liu, J. , Y. Ko, B. Wu, Y. Liang et al., 14-3-3? induces heat shock protein 70 expression in hepatocellular carcinoma, BMC Cancer, vol.14, p.425, 2014.
DOI : 10.1186/1471-2407-14-425

URL : https://doi.org/10.1186/1471-2407-14-425

G. H. Kang, B. S. Lee, E. S. Lee, S. H. Kim, H. Y. Lee et al., Prognostic significance of p53, mTOR, c-Met, IGF-1R, and HSP70 overexpression after the resection of hepatocellular carcinoma, Gut Liver, vol.8, issue.1, pp.79-87, 2014.

H. W. Lee, E. H. Lee, S. Kim, M. S. Roh, S. B. Jung et al., Heat shock protein 70 (HSP70) expression is associated with poor prognosis in intestinal type gastric cancer, Virchows Arch Int J Pathol, vol.463, issue.4, pp.489-95, 2013.
DOI : 10.1007/s00428-013-1461-x

K. Bauer, U. Nitsche, J. Slotta-huspenina, E. Drecoll, C. H. Von-weyhern et al., High HSP27 and HSP70 expression levels are independent adverse prognostic factors in primary resected colon cancer, Cell Oncol Dordr, vol.35, issue.3, pp.197-205, 2012.
DOI : 10.1007/s13402-012-0079-3

B. Farkas, M. Hantschel, M. Magyarlaki, B. Becker, K. Scherer et al., Heat shock protein 70 membrane expression and melanoma-associated marker phenotype in primary and metastatic melanoma, Melanoma Res, vol.13, issue.2, pp.147-52, 2003.
DOI : 10.1097/00008390-200304000-00006

O. Sagol, B. Tuna, A. Coker, S. Karademir, F. Obuz et al., Immunohistochemical detection of pS2 protein and heat shock protein-70 in pancreatic adenocarcinomas. Relationship with disease extent and patient survival, Pathol Res Pract, vol.198, issue.2, pp.77-84, 2002.

K. Nanbu, I. Konishi, M. Mandai, H. Kuroda, A. A. Hamid et al., Prognostic significance of heat shock proteins HSP70 and HSP90 in endometrial carcinomas, Cancer Detect Prev, vol.22, issue.6, pp.549-55, 1998.

K. Szondy, K. Rusai, A. J. Szabó, A. Nagy, K. Gal et al., Tumor cell expression of heat shock protein (HSP) 72 is influenced by HSP72 [HSPA1B A(1267)G] polymorphism and predicts survival in small Cell lung cancer (SCLC) patients. Cancer Invest, vol.30, pp.317-339, 2012.

E. Malusecka, S. Krzyzowska-gruca, J. Gawrychowski, A. Fiszer-kierzkowska, Z. Kolosza et al., Stress proteins HSP27 and HSP70i predict survival in non-small cell lung carcinoma, Anticancer Res, vol.28, issue.1B, pp.501-507, 2008.

K. S. Mäkelä, J. A. Haapasalo, J. M. Ilvesaro, S. Parkkila, T. Paavonen et al., Hsp27 and its expression pattern in diffusely infiltrating astrocytomas, Histol Histopathol, vol.29, issue.9, pp.1161-1169, 2014.

E. M. Tweedle, I. Khattak, C. W. Ang, T. Nedjadi, R. Jenkins et al., Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer, Gut, vol.59, issue.11, pp.1501-1511, 2010.
DOI : 10.1136/gut.2009.196626

C. Giaginis, S. S. Daskalopoulou, S. Vgenopoulou, I. Sfiniadakis, G. Kouraklis et al., Heat Shock Protein-27,-60 and-90 expression in gastric cancer: association with clinicopathological variables and patient survival, BMC Gastroenterol, vol.9, p.14, 2009.
DOI : 10.1186/1471-230x-9-14

URL : https://bmcgastroenterol.biomedcentral.com/track/pdf/10.1186/1471-230X-9-14

H. Uozaki, T. Ishida, C. Kakiuchi, H. Horiuchi, T. Gotoh et al., Expression of heat shock proteins in osteosarcoma and its relationship to prognosis, Pathol Res Pract, vol.196, issue.10, pp.665-73, 2000.

L. Muzio, L. Leonardi, R. Mariggiò, M. A. Mignogna, M. D. Rubini et al., HSP 27 as possible prognostic factor in patients with oral squamous cell carcinoma, Histol Histopathol, vol.19, issue.1, pp.119-147, 2004.

C. Schäfer, H. Seeliger, D. C. Bader, G. Assmann, D. Buchner et al., Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma, Trends Biochem Sci, vol.16, issue.8, pp.311-334, 2012.

M. Shiota, J. L. Bishop, K. M. Nip, A. Zardan, A. Takeuchi et al., Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer, Cancer Res, vol.73, issue.10, pp.3109-3128, 2013.

X. Wang, M. Chen, J. Zhou, and X. Zhang, HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review), Int J Oncol, vol.45, issue.1, pp.18-30, 2014.

A. Arrigo,

, Med Sci MS, vol.21, issue.6-7, pp.619-644, 2005.

G. Jego, A. Hazoumé, R. Seigneuric, and C. Garrido, Targeting heat shock proteins in cancer, Cancer Lett

M. Y. Sherman and V. L. Gabai, Search of: Recruiting, Active, not recruiting, Completed, Enrolling by invitation, Unknown status Studies | HSP inhibitor-List Results-ClinicalTrials.gov, Oncogene, vol.332, issue.2, pp.4153-61, 2015.

J. C. Heinrich, S. Donakonda, V. J. Haupt, P. Lennig, Y. Zhang et al., New HSP27 inhibitors efficiently suppress drug resistance development in cancer cells, Oncotarget, vol.7, issue.42, pp.68156-69, 2016.

H. Khalid, K. Tsutsumi, H. Yamashita, M. Kishikawa, A. Yasunaga et al., Expression of the small heat shock protein (hsp) 27 in human astrocytomas correlates with histologic grades and tumor growth fractions, Cell Mol Neurobiol, vol.15, issue.2, pp.257-68, 1995.

G. A. Alexiou, A. Karamoutsios, G. Lallas, V. Ragos, A. Goussia et al., Expression of heat shock proteins in brain tumors, Turk Neurosurg, vol.24, issue.5, pp.745-754, 2014.